mf3 - hypertension

Upload: annbe-barte

Post on 14-Apr-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 MF3 - Hypertension

    1/27

    HYPERTENSIONDEBBIE ROSE CABANERO

  • 7/30/2019 MF3 - Hypertension

    2/27

    Doubles the risk of cardiovascular

    disease

    Coronary heart disease

    Congestive heart failurePeripheral arterial disease

    Stroke

    Renal failure

  • 7/30/2019 MF3 - Hypertension

    3/27

    epidemiology

    Varies among countries

    Present in all populations

    6% death worldwide Children and adolescents blood pressure is

    associated with growth and maturation

    Average systolic BP ( >140mmHg) higher for man early adulthood

    Older women 60 up

  • 7/30/2019 MF3 - Hypertension

    4/27

    Dystolic pressure(>90 mmHg)

    Adults increase until 55 yrs then decrease Consequence is widening of pulse pressure beyond age

    60

    Both environmental and genetic factors

    Obesity/ wt gain

    High nacl intake

    Low dietary intake of calcium and potassium

    Alcohol consumption, psychosocial stress,

    decrease level of physical activity

  • 7/30/2019 MF3 - Hypertension

    5/27

    Mechanism of hypertension

    Cardiac output

    Stoke volume and heart

    rate Myocardial

    Contractility

    Size of vascular

    compartment

    Peripheral resistance

    Functional and anatomic Changes in small arteries and

    arterioles

  • 7/30/2019 MF3 - Hypertension

    6/27

    Intravascular volume

    Primary determinant of arterial pressure overlong term

    Extracellular fluid space- composed of vascular

    and interstitial spaces Sodium- extracellular ion primary determinant

    of extracellular fluid volume

    Blood flow = pressure across the vascular bedVascular resistance

    Many vascular beds have capacity to autoregulateblood flow

  • 7/30/2019 MF3 - Hypertension

    7/27

    Arterial pressure increase = urinary sodium

    excretion increase and sodium balance

    maintained

    Pressure natriuresis phenomenon

    Increase glomerular filtration rate

    Decrease absorbing capacity of renal tubules and

    hormonal factors

  • 7/30/2019 MF3 - Hypertension

    8/27

    Autonomic nervous system

    Adrenergic reflexes modulate BP over shortterm and long term regulator of arterialpressure

    3 endogenous catecholamines Norepinephrine

    Epinephrine

    Dopamine Neuron neurotransmitter synaptic cleft

    receptor sites / target tissue

  • 7/30/2019 MF3 - Hypertension

    9/27

  • 7/30/2019 MF3 - Hypertension

    10/27

    RENIN ANGIOTENSIN ALDOSTERONE

  • 7/30/2019 MF3 - Hypertension

    11/27

    VASCULAR MECHANISM

    Vascular radius and compliance of resistance arteriesare important determinants of arterial pressure

    Remodeling alterations in vessel wall withoutchanging vessel volume (hypertrophic, eutrophic)

    Ion transport contribute to hypertension associated

    with abnormalities of vascular tone Na+ - H+ exchange increase hypertension

    Increase vascular tone

    1st: increase in Na entry increase vascular tone by

    activation Na+ - CA2 + exchange = increase intracellularcalcium

    2nd : increase PH enhances calcium sensitivity increasecontractility

  • 7/30/2019 MF3 - Hypertension

    12/27

    Pathologic consequences of

    hypertension Heart

    most common cause of death in hypertensive patients

    Diastolic dysfunction early consequence of hypertension

    Brain Risk factor for brain infarction and hemorrhage

    Impaired cognition encephalopathy

    Kidney Primary renal disease is the most common etiology of secondary hypertension

    Direct damage to glomerular capillaries

    Renal tubules ischemic - atrophic

    Peripheral Arteries blood vessels may be a target organ for atherosclerotic disease secondary to

    long-standing elevated blood pressure

  • 7/30/2019 MF3 - Hypertension

    13/27

    Clinical d/o of hypertension

    Essential hypertension

    Aka primary / idiopathic

    Familial , genetic, environmental

    Increase w/ age

    Peripheral resistance increase, cardiac output

    normal/ decrease

    High plasma renin activity vasoconstrictor formof hypertension

    Low renin volume dependent hypertension

  • 7/30/2019 MF3 - Hypertension

    14/27

    HYPERTENSION

    Home blood pressure are lower than in the clinics

    white coat hypertension BP higher in the early morning hrs soon after

    walking

    Blood Pressure Classification Systolic, mmHg Diastolic, mmHg

    Normal

  • 7/30/2019 MF3 - Hypertension

    15/27

    Secondary hypertension

    Renal parenchymal diseases

    -renal disease is the most common cause of secondaryhypertension

    -proteinuria

    Renovascular hypertension- Due to obstruction of renal artery ,curable

    - Pt at risk

    -Older atherosclerotic pt. who have plaque

    Obstructing the renal artery-pt with fibromuscular dyplasia (women)

    - affect bilaterally, distal portion of renal artery

    - Have abdominal bruit

  • 7/30/2019 MF3 - Hypertension

    16/27

    Positive study:

    1. Decrease relative uptake by involved kidney

    2. Delayed uptake on affected side3. Delayed washout on affected side

    PRIMARY ALDOSTERONISM

    Consequences : sodium retention, hypertension,hypokalemia

    3rd- 4th decade of life

    Glucose intolerance

    Polyuria, polydypsia, paresthesia or muscularweakness, hypokalemia alkolosis

    Aldosterone producing adrenal adenoma Tumor unilateral

  • 7/30/2019 MF3 - Hypertension

    17/27

    Cushing syndrome

    S timulation of mineralocorticoid receptors by cortisol

    and increase secretion of adrenal steroids

    obstuctive sleep apnea

    Coarctation of the aorta

    Most common congenital cardiovascular cause ofhypertension

    Occur in children with turners syndrome

    Dimished and delayed femoral pulses and systolic

    pressure gradient between right arm and legs Blowing systolic murmur may be heard in the post.

    Left interscapular areas

  • 7/30/2019 MF3 - Hypertension

    18/27

    Monogenic hypertension

    Deficiency in sex hormones and cortisol

    Males: pseudohermaphoditism

    Females: primary amenorrhea, absent secondary

    characteristics

  • 7/30/2019 MF3 - Hypertension

    19/27

    Approach to patient

    Measurement of BP

    Before taking the blood pressure measurement,the individual should be seated quietly for 5 min

    in a private, quiet setting with a comfortable roomtemperature

    center of the cuff should be at heart level

    width of the bladder cuff should equal at least

    40% of the arm circumference length of the cuff bladder should encircle at least

    80% of the arm circumference

  • 7/30/2019 MF3 - Hypertension

    20/27

    Methods in determining BP

    Auscultatory method

    Stethoscope over antecubital area

    BP cuff inflated over upper arm

    Korotkoff sounds

    Mechanism:

    When cuff pressure is higher than systolic P, brachial arteryremains occluded

    As cuff pressure is reduced, blood jets through the artery,hearing tapping sounds from antecubital artery

    When cuff pressure is equal diastolic pressure, blood nolonger jets through squeezed artery, tapping stops

  • 7/30/2019 MF3 - Hypertension

    21/27

    treatment Diuretics

    Increase the formation and excretion of urine

    Decreasing the fluid within vascular system

    Often first type of drugs to treat hypertension

    Classification Thiazide

    Act a distal tubule of the nephron, inhibit sodium reabsorption

    Loop Act on the ascending limb of the loop of henle.

    Inhibiting the reabsorption of sodium and chloride from thenephron, preventing reabsorption of water

    Potassium sparing Prevent potassium secretion into distal tubule

    Sodium is reabsorbed, potassium is secreted

  • 7/30/2019 MF3 - Hypertension

    22/27

    Sympatholytic drugs

    Increase sympathetic activity

    Beta adrenergic blockers Decrease BP, mainstay of antihypertensive therapy

    Primary effect on the heart

    Alpha blockers

    Decrease in vascular resistance, directly act on theperipheral vasculature

    Presynaptic adrenergic inhibitors

    Inhibits the release of norepinephrine Centrally acting agents

    Inhibit sympathetic discharge from the brainstem

  • 7/30/2019 MF3 - Hypertension

    23/27

    Ganglionic blockers Block synaptic transmission at autonomic ganglia, reduce BP by

    decreasing systemic sympathetic activity

    Nicotinic cholinergic antagonists block transmission bet.Presynaptic and postsynaptic neurons

    Vasodilators Directly vasoldilate peripheral vasculature

    Decreasing peripheral vascular resistance

    Inhibit smmoth muscle contraction ACE inhibitors

    Decrease BP in pt who do not have a substantial increase incirculating renin

    Preventing the adverse structural changes

    Calcium channel blockers Block calcium entry into vascular smooth- muscle cells

    Inhibit contractile process leading to vasodilation and decreasevascular resistance

    T t t

  • 7/30/2019 MF3 - Hypertension

    24/27

    Treatment

  • 7/30/2019 MF3 - Hypertension

    25/27

  • 7/30/2019 MF3 - Hypertension

    26/27

    LIFESTYLE intervention

    Weight reduction Attain and maintain BMI < 25 kg/m2

    Dietary salt reduction < 6 g NaCl/d

    Adapt DASH-type dietary plan Diet rich in fruits, vegetables, and low-fatdairy products with reduced content of

    saturated and total fat

    Moderation of alcohol consumption For those who drink alcohol, consume 2

    drinks/day in men and 1 drink/day inwomen

    Physical activity Regular aerobic activity, e.g., brisk walking

    for 30 min/d

  • 7/30/2019 MF3 - Hypertension

    27/27

    Blood pressure may be lowered by 30 min of

    moderately intense physical activity, such asbrisk walking, 67 days a week, or by more

    intense, less frequent workouts

    Alcohol use in persons consuming three ormore drinks per day

    DASH (Dietary Approaches to Stop

    Hypertension) - 8-week period a diet